Search - tctmd.com

Displaying 621 - 640 of 1725

Sort: Relevancy | Date

Presentation TCT 2019

TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

Presenter: Usman Baber

September 26, 2019

News Conference News TCT 2019

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Todd Neale

September 26, 2019

News Conference News TCT 2019

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

L.A. McKeown

September 26, 2019

Presentation TCT 2019

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor-Plus-Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI

Presenter: Roxana Mehran

September 26, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

Presentation TCT 2019

Case Resolution: How Did I Treat This Case?

Presenter: Pengcheng He

September 26, 2019

Presentation TCT 2019

How Would I Treat?

Presenter: Qi Zhang

September 26, 2019

Presentation TCT 2019

How Would I Treat?

Presenter: YONG HE

September 26, 2019

Presentation TCT 2019

How Would I Treat?

Presenter: Jun Pu

September 26, 2019

Presentation TCT 2019

Case Introduction

Presenter: Pengcheng He

September 26, 2019

Presentation TCT 2019

Keynote Lecture 2: Intracoronary Imaging Guidance for High-Risk PCI

Presenter: Junjie Zhang

September 26, 2019

Presentation TCT 2019

Case Resolution: How Did I Treat This Case?

Presenter: Lily Li

September 26, 2019

Presentation TCT 2019

How Would I Treat?

Presenter: Yong Zeng

September 26, 2019

Presentation TCT 2019

How Would I Treat?

Presenter: Bill Gogas

September 26, 2019

Presentation TCT 2019

How Would I Treat?

Presenter: Ning Guo

September 26, 2019

Presentation TCT 2019

Case Introduction

Presenter: Lily Li

September 26, 2019

Presentation TCT 2019

Keynote Lecture 1: Current Approach for Left Main Bifurcation Stenting

Presenter: Shao-Liang Chen

September 26, 2019

News Daily News

Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS

Caitlin E. Cox

September 20, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Conference News ESC 2019

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

Caitlin E. Cox

September 10, 2019

Advertisement

TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor-Plus-Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Case Resolution: How Did I Treat This Case?

How Would I Treat?

How Would I Treat?

How Would I Treat?

Case Introduction

Keynote Lecture 2: Intracoronary Imaging Guidance for High-Risk PCI

Case Resolution: How Did I Treat This Case?

How Would I Treat?

How Would I Treat?

How Would I Treat?

Case Introduction

Keynote Lecture 1: Current Approach for Left Main Bifurcation Stenting

Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content